|
|
TTD Drug ID:
DNC000152
Drug
Information |
Name | Act1 | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-1 9)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13-,14+,15-,1 6+/m1/s1 | InChIKey | STECJAGHUSJQJN-USLFZFAMSA-N | Canonical SMILES | CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4 | Isomeric SMILES | CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4 | CAS Number | CAS 114-49-8 | PubChem Compound ID | CID 3000322. | SuperDrug ATC ID | A04AD01 | SuperDrug CAS ID | 000051343; | Target | Nuclear factor NF-kappa-B |  | Activator | [1] | Ref 1 | Act1, an NF-kappa B-activating protein. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10489-93. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|